Proposed Rules Address Prescription Drug Pricing

Last week, the Department of Health and Human Services (HHS) released a proposed rule to lower prescription drug prices and out-of-pocket costs by encouraging manufacturers to pass discounts directly to patients and bring new transparency to prescription drug markets. Please note, nothing has changed yet, as this is only a proposed rule. Even if finalized in its current…

A Bitter Pill: The High Cost of Specialty Drugs

The good news: Pharmaceutical companies are developing a range of drugs to treat diseases that are chronic and/or rare. The bad news: Their high (some might say outrageous) cost. Overall, prescription drug prices rose 12 percent in 2014. Sales of specialty drugs contributed greatly to the jump. Specialty drugs: Are usually self-administered, high cost, injectable…